Mentice Year-end Report Q4, Oct - Dec 2022
READ MORE
REGISTER
REGISTER FOR THE MENTICE YEAR-END REPORT Q4 OCT - DEC 2022 EARNINGS CALL
READ MORE
REGISTER

Mentice receives order of total SEK 6.0 million from Abbott EP

Monday, June 29, 2020

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, receives order from Abbott EP for the segment Medical Device Industry. The order covers system sales and development to be delivered during the third quarter 2020. The total order value amounts to SEK 6.0 million and will be accounted for in the order book for the second quarter 2020.

The order covers development of additional functionality and the delivery of a global fleet of ultraportable simulators for internal and physician education to be delivered during the third quarter 2020. The order will be accounted for in the order book for the segment Medical Device Industry during the second quarter 2020. The total value for the order amounts to SEK 6.0 million.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: 
goran.malmberg@mentice.com

US Mobile. +1 (312) 860 5610

Sweden Mobile +46 (0) 703 09 22 22

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, at 08.00 on June 29, 2020.  

Marketplace| Nasdaq First North Premier, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399

Mentice Bokslutskommuniké, Jan - Dec 2022
LÄS MER
REGISTRERA DIG FÖR MENTICE BOKSLUTSKOMMUNIKE OKT - DEC 2022 WEBCAST
LÄS MER

Mentice receives order of total SEK 6.0 million from Abbott EP

Monday, June 29, 2020

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, receives order from Abbott EP for the segment Medical Device Industry. The order covers system sales and development to be delivered during the third quarter 2020. The total order value amounts to SEK 6.0 million and will be accounted for in the order book for the second quarter 2020.

The order covers development of additional functionality and the delivery of a global fleet of ultraportable simulators for internal and physician education to be delivered during the third quarter 2020. The order will be accounted for in the order book for the segment Medical Device Industry during the second quarter 2020. The total value for the order amounts to SEK 6.0 million.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: 
goran.malmberg@mentice.com

US Mobile. +1 (312) 860 5610

Sweden Mobile +46 (0) 703 09 22 22

This information is information that Mentice AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person, at 08.00 on June 29, 2020.  

Marketplace| Nasdaq First North Premier, Stockholm | Ticker symbol MNTC

Certified Adviser| FNCA Sweden AB, phone +46 8 528 00 399